The “Spaced Repetition Learning Project,” launched by Ali Raif Pharmaceuticals to enhance its field teams’ learning experience, won a Gold Award at the 2026 Brandon Hall Group HCM Excellence Awards®. The project received a Gold Award in the “Best Custom Content Learning” category at the 2026 Brandon Hall Group HCM Excellence Awards®, which recognize innovative […]
- Login / Register
- 0 items - ₺0.00
- English
NEWS
Bronze Awards at Brandon Hall & Stevie Awards 2025 Ali Raif Pharmaceuticals has been honored with two prestigious international awards in recognition of its innovative approach to employee development and the opportunities it provides for young talent. At the 2025 Brandon Hall Group HCM Excellence Awards, the company received a Bronze Award in the Learning […]
Ali Raif Pharmaceuticals Tops Trademark Filings from Its R&D Center Results have been announced for Türkiye’s Top 250 Companies with the highest R&D spending. Turkishtime’s 2023 R&D 250 Research has ranked Ali Raif İlaç ranked first in the number of trademarks secured at its R&D Center. Turkishtime’s 11th annual cross-sector report on Turkish industry draws […]
Ali Raif İlaç joined the pharmaceutical industry in 1963 to “add value to life,” and celebrates its lifetime success on its 60th anniversary. Ali Raif İlaç has always upheld its values and pursued innovative and future-oriented interests in products and services for the benefit of public health. The firm has pioneered many perspectives and achievements […]
The Ali Raif Human Resources Directorate team won the third-place award in the 2022 TEGEP Education and Development Awards, organized by the Association of Education and Development Platform of Turkey. Since 2015, the TEGEP Education and Development Awards celebrates the best corporate education and development practices in Turkey to promote and recognize good practices. And […]
The economy and business portal Turkishtime published its ninth annual R&D 250 research. Based on 2021 data, Ali Raif became one of the “Highest R&D Spenders in Turkey” and placed fifth in all industries and fourth in the pharmaceutical industry in terms of the number of trademarks obtained in the R&D center. Ali Raif draws […]
August 2021 Fortune magazine continues to rank the largest companies in Turkey, just as it does in the United States, based on annual net turnover, exports, and profitability before tax, etc. Ali Raif İlaç continues its steady climb on the Fortune 500 List, which saw its 14th instalment this year. The Fortune 500 list includes […]
The Company Aims to Quadruple its Production Capacity Established in 1928, Ali Raif İlaç Sanayi has a deep-rooted history and an important place in the Turkish pharmaceutical industry with its 58 years of experience in the field. The company has now taken an important step in line with its growth targets and broke ground for […]
Ali Raif İlaç Sanayi, a 57-year pharmaceutical company serving the Turkish healthcare industry, has undergone a change of management. Serving as a General Manager for 32 years, Muzaffer Bal handed over to Nihal Arslan, who has been working in various positions at the company since 1990 and has been the Deputy General Manager of Marketing […]
Ali Raif İlaç Sanayi became the “curiosity sponsor” of 120 children in the Science Campaign organized by the Young Guru Academy (YGA), a non-governmental organization, to spread the motto “Adding Value to Life” as part of the Mother’s Day celebrations. The company sponsored the curiosity of 60 fifth- and sixth-grade students at Şehit Serkan Angay […]
“Inside life, inside health” Ali Raif İlaç Sanayi (ARİS) is a well-established and leading organization of the Turkish pharmaceutical industry. The company has added value to Turkish medicine with the mission of “protecting and improving human health” for 55 years and has achieved its objective to expand its fields of treatment with Aris Life. Empowered […]
Cancer is one of the most serious health problems today, and its incidence and prevalence are continuously increasing. Early diagnosis plays a crucial role in successfully fighting this disease. Health authorities, physicians, nongovernmental organizations, patient associations, patients, patients’ relatives, other healthcare professionals and the pharmaceutical industry are the stakeholders in the struggle against cancer. Ali […]
- 1
- 2